Press releases | UCB
UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

2 Feb 2022

Transparency notification FMR LLC.

Read More
2 Feb 2022

UCB Receives Positive CHMP Opinion Recommending Approval of BRIVIACT[®] (brivaracetam) and VIMPAT[®] (lacosamide) in the EU for Partial-Onset Seizures in Pediatric Patients From Two to Four Years

Read More
1 Feb 2022

UCB Commences Tender Offer to Acquire Zogenix, Inc.

Read More
28 Jan 2022

Disposals of own shares

Read More
24 Jan 2022

BIMZELX[®] (bimekizumab) Approved in Japan for the Treatment of Plaque Psoriasis, Generalized Pustular Psoriasis and Psoriatic Erythroderma

Read More
21 Jan 2022

Disposals of own shares

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe